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INTRODUCTION
PATIENT SELECTION AND PREOPERATIVE
ASSESSMENT
There has been an impressive advancement in
laparoscopic techniques since its introduction in the
20th century . Laparoscopy, initially used for
diagnostic purposes, has been expanded to include
operative surgery and currently, is widely and
popularly used for daycase laparoscopic procedures.
The morbidity and mortality initially associated with
laparoscopy has greatly reduced over the years as a
result of improved skills and modern technology .
There is also an improvement in the management of
postoperative pain and in the actions that are taken to
prevent potential complications such as nausea and
vomiting, dizziness, delayed mobilization as well as
pulmonary and haemodynamic disturbances.
Laparoscopic procedures may soon become routine
in a number of teaching hospitals in Nigeria because
some of them were recently equipped with high
resolution video cameras and television monitors via
the VAMED project of the Federal Government of
Nigeria . This article presents current anaesthetic
management; describes laparoscopic gynaecological
procedure; addresses patient selection, anaesthetic
implications, perioperative anaesthetic management
and the anaesthetic agents and adjuvants currently
available for daycase laparoscopic procedures.
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bilateral clip sterilization and dye test are standard
daycase procedures. Not all patients are suitable for
daycase surgery, no matter how 'minimally invasive'
the surgery may be. For example, ovarian cystectomy
for the removal non-cancerous cysts can be performed
laparoscopically but the average hospital stay is 3-7
days. Only American Society of Anesthesiology
(ASA) Class I or II patients are preferred for daycase
procedures because they tolerate better the
phys io logica l e ffec ts of carbon dioxide
pneumoperitoneum and the variations in positioning
when compared with ASA III and IV patients . In
addition, the presence of pre-existing diseases which
may be seen in ASA III and IV patients has been
associated with a higher risk of perioperative
morbidity and mortality. For example asthma has been
associated with respiratory events; hypertension with
cardiovascular complications; and gastroesophageal
reflux disease with adverse intubation events . Some
hospitals well established for daycase surgery, may
have a daycase unit (DCU) dedicated for the reception
and the general care of their patients. The advantage is
that daycase surgery and anaesthesia can be developed
as a sub-specialty. Irrespective of the type and structure
of the daycase unit, there is still a need for a well
established inpatient facility for managing patients
when complications occur. Moreover, high risk
patients that require laparoscopy can be admitted and
managed as in-patients.Preoperative assessment of
patients for daycase laparoscopic procedures can be
performed by using assessment forms or computerized
questionnaires to obtain information about the patient's
medical condition, previous operations, drug and
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Laparoscopy for gynaecological procedures is minimally invasive and is mostly performed as a daycase. The
advancement of laparoscopy and minimal access surgery has greatly influenced the evolution of anaesthetic
techniques. Preoperative assessment can be simplified by the use of questionnaires in pre-assessment clinics.
Intraoperative intravenous fluid administration improves patient well being while airway management can be by
the age-old, tried and trusted orotracheal tube or by the newer laryngeal mask airways.
The use of propofol as an induction agent, a short acting non-depolarizing muscle relaxant e.g. mivacurium, an
inhalational anaesthetic agent with a fast wake up time e.g. sevoflurane or desflurane, and short acting opioids
e.g. fentanyl guarantees quick recovery of patients. The trend towards a multimodal approach to postoperative
pain and prevention of postoperative nausea and vomiting (PONV) improves postoperative profile of day case
gynaecological patients. Expertise in providing a pneumoperitoneum with carbon dioxide is desirable even as
other options for lifting the abdominal wall are being investigated.
Gynaecological Laparoscopy, Daycase,Anaesthesia, Current trends.
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systems. Pre-assessment clinics could be consultant-
led and nurse-run . Routine preoperative test is
unnecessary in this group of patients but hemoglobin
test is essential in women below the age of 40. This is
to exclude anaemia that can result from monthly
menstruation and from postpartum haemorrhage.
Laparoscopic procedures require the creation of a
pneumoperitoneum and a steep Trendelenburg
position in order to visualize the pelvic structures.
Both actions have anaesthetic implications. With the
use of the laparoscope (fine telescope), instruments
are passed into the abdomen to enable the
gynaecologist to operate. The operative field can be
visualized by high resolution television camera. At
the end of the operation, the abdomen is deflated and
a stitch is placed in the small wound. Carbon dioxide
pneumoperitoneum produces pulmonary and
haemodynamic disturbances that are worse in the
spontaneously breathing patient. A head down
(Trendelenburg) position causes both splinting of the
abdomen and reduction of the functional residual
capacity. The patient undergoing laparoscopy is
thereby prone to hypoxaemia and hypercarbia .
Hypercarbia may stimulate the sympathetic nervous
system resulting in an increase in the heart rate with
the possible risk of arrhythmia. Other effects of
carbon dioxide pneumoperitoneum include an
increased mean arterial pressure, systemic vascular
resistance (SVR), and increase in central venous
pressure with resultant decrease in cardiac output
and stroke volume. In order to avoid these problems,
a general anaesthetic using a relaxant technique with
effective mechanical ventilation of the lungs is
preferred. However being a relatively short
procedure, it is essential that the drugs administered
must have a quick onset and offset. The use of local
anaesthetics as the sole agent for laparoscopic
procedures must be discouraged because of the
associated awareness and anxiety produced in the
patient. It may be particularly distressing for the
patient when placed head down and during the
creation of a pneumoperitoneum thereby worsening
the haemodynamic disturbances.
Venous access must be established for the
administration of the intravenous drugs and for the
possible administration of fluids or vasopressors
when required. Intravenous fluids are not usually
required because commonly, there is no associated
fluid or blood loss during laparoscopic procedures.
However, preoperative administration of 2ml/kg of
sodium lactate infusion for every hour of fasting has
been found to reduce PONV and post operative pain










Irrespective of the duration of surgery and
anaesthesia, all patients must be monitored and
treated based on evidence. Patient's physiological
state and depth of anaesthesia need continuous
assessment perioperatively. Clinical observations of
patient's mucosal colour, pupil size, and response to
surgical stimuli, chest wall movements, palpitations
of pulse as well as auscultation of breath sounds must
be combined with the use of the recommended
standard monitoring devices . The monitoring
devices essential to the safe conduct of anaesthesia
include the pulse oximeter, non-invasive blood
pressure monitor, electrocardiograph, capnograph
for airway gases: oxygen, carbon dioxide and vapour
as well as airway pressure.
The cuffed orotracheal tube (COTT) remains the
safest, time tested technique of airway management
during laparoscopy and is the yardstick for
measuring the efficacy of other airway devices . It
protects the airway better from the risk of
regurgitation that may result from increased intra-
abdominal pressure during in-sufflation. Inadvertent
endobronchial intubation which may occur
intraoperatively from changes in patient positioning,
e s p e c i a l l y w i t h t h e i n t r o d u c t i o n o f
pneumoperitoneum and trendelenburg positioning
must be prevented . Fortunately, this can be detected
by increased airway pressure and desaturation, early
in the procedure, without an increase in end tidal
carbon dioxide. The laryngeal mask airway (LMA)
provides an alternative to ventilation through a
cuffed orotracheal tube. It is easier to insert and does
not require muscle relaxants for insertion . Its use is
contraindicated in patients with pharyngeal
pathology and obstruction, full stomach, high airway
resistance (e.g. bronchospasm) as well as low
pulmonary compliance (e.g. obesity). The
misgivings about the safety of the LMA include
partial protection of the larynx from pharyngeal
secretions; malfunction, if not properly inserted
resulting in gastric distention and regurgitation; and
failure as a result of down folding of the epiglottis or
the distal cuff . All these can be prevented or
minimized by proper insertion. However, the LMAis
not safety-proof for gastric regurgitation therefore;
safety precautions must be taken, such as, inflating
the cuff with the correct amount of air and ensuring
adequate depth of anaesthesia. Pharyngeal
suctioning and cuff deflation must be avoided until
the patient is awake and has regained full airway
control. The LMA has been successfully used in a
large number of gynecological laparoscopic
procedures . The use of a newer supraglottic
airway device i.e. the cobra perilaryngeal airway
(PLA) for controlled venti lat ion during
gynaecological laparoscopy is a potential alternative
to the OTT and LMA . The “oesophageal-tracheal








placed in the oesophagus for aspiration protection
during prolonged laparoscopic surgery but this is
more costly than the orotracheal tube and does not
provide an added advantage for the short daycase
procedures .
Propofol is the preferred induction agent for daycase
laparoscopic procedures because of improved
postoperative recovery and faster recovery of
consciousness when compared with thiopentone .
It depresses airway reflexes more potently than
thiopentone. Propofol has also been shown to result
in a reduction in the incidences of nausea and
vomiting thereby reducing the requirement for the
use of antiemetics . Propofol and low dose (1-2 ug
/kg) fentanyl capitalize on the hypnotic and
analgesic property of each drug, respectively. The
combined use of propofol and opioids, notably
fentanyl and alfentanil, may be associated with a
transient bradycardia and hypotension; however this
is balanced by the opposing effect of carbon dioxide
pneumoperitoneum. The mu-receptor ultrashort
acting agonist, remifentanil, is popularly used for
daycase gynaecological surgery. Remifentanil
undergoes hydrolytic metabolism by blood and
tissue esterases and this ensures a rapid termination
of the drug effect. Because of its rapid clearance and
blood-brain equilibration time of 60-90 seconds, it is
administered as an infusion in the busy outpatient
setting allowing for fast-tracking and bypassing of
the recovery room (post anaesthesia care unit .
Volatile induction and maintenance of anaesthesia
(VIMA) with sevoflurane provides a smooth
transition from induction to maintenance phase. Of
the entire currently available volatile anaesthetic
agents, sevoflurane is the least irritating to the
respiratory tract and in addition provides a fast wake-
up time because of it low blood/gas partition
coefficient of 0.69 making it the preferred
inhalational anaesthetic for daycase. The other
volatile agents namely halothane, isoflurane and
enflurane may be used but must be turned off on time
to avoid prolongation of recovery. Although,
desflurane like sevoflurane has a fast wake up time, it
is irritating to the respiratory tract and is thus
preferred for maintenance alone. There is a
significant postoperative nausea and vomiting rate
with VIMA even where opioids are omitted .
Nitrous oxide should be used with caution as an
adjuvant for inhaled anaesthesia because it may
a c c u m u l a t e i n t h e c a r b o n d i o x i d e
pneumoperitoneum and worsen the consequences of
gas embolism. It can also introduce a fire risk. The










The ideal muscle relaxant for daycase procedures
should provide adequate paralysis within a clinically
acceptable time of onset (<3min), be capable of rapid
pharmacological antagonism if required, have
minimal side effects, be non-cumulative on repeat
dosing and have a short duration of action of about 15-
20 min. Daycase laparoscopy demands greater
flexibility in the use of a muscle relaxant than do most
other operations, since the operating time can vary
from 10 minutes to 45 minutes or more and the
completion of the operation can be relatively sudden
and unexpected. The administration of the short acting
depolarizing muscle relaxant (e.g. suxamethonium)
using an infusion pump and titrating it as required,
while providing ideal conditions, has drawbacks.
These include postoperative muscle pain, the risk of
phase 2 block with higher doses, the rare problem of
atypical plasma cholinesterase, and the rare
association of malignant hyperthermia . The
intermediate non-depolarizing muscle relaxants such
as vecuronium, atracurium, cis-atracurium,
rocuronium and mivacurium possess many of the ideal
characteristics. Mivacurium has the shortest duration
of action of all the currently used non-depolarizing
agents and recovery from it is more rapid.
Furthermore, it does not require pharmacological
antagonism. Though it is metabolized by human
plasma cholinesterase like suxamethonium, the
myalgia, hyperkalaemia, bradycardia, and problems of
phase 2 block that may be associated with
suxamethonium are not seen with mivacurium .
Rapacuronium offered an excellent neuromuscular
profile for short surgical procedures needing muscle
relaxation but has been withdrawn because of its
undesirable respiratory side effects i.e. increased
airway pressure and bronchospasm .
The use of an anti-emetic reduces the risk of nausea
and vomiting, irrespective of the anaesthetic agents
used. Postoperative nausea and vomiting (PONV) is a
complication seen in 70% of patients undergoing
gynaecological laparoscopic procedures and thus a
major concern . Different anti-emetics given on their
own have shown different results in the past.
Ondansetron was found to be 80% more effective
w h e n c o m p a r e d w i t h d r o p e r i d o l a n d
prochlorperazine . A clinical trial carried out by Fujii
et al reported complete control of nausea or vomiting
in 88% of the granisetron group, droperidol 60% and
metoclopramide 55%. The available 5-HT receptor
antagonists i.e ondansetron, granisetron, dolasetron
and tropisetron are not different in efficacy or side-
effect profile when appropriate doses were used for the
management of PONV . Midazolam, a water soluble
benzodiazepine has been established to have anti-
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effectively reduces the frequency of PONV in
patients undergoing daycase surgery . A recent
comparison of Midazolam with ondansetron
confirmed that Midazolam 2mg given intravenously
before the end of surgery was as effective as
ondansetron 4mg in decreasing PONV . Although
ondansetron is now generic and the cost has come
down significantly, it is still about ten times the cost
of midazolam, making midazolam a cost effective
choice. There is a growing trend towards the use of
combination antiemetic therapy. For example the
risk of PONV was shown to be reduced when
cyclizine and granisetron were given together than
with either given alone . The combined use of
ranitidine and metoclopramide for premedication is
cost effective and produces excellent antiemetic
effect. This is because ranitidine decreases acidity of
gastric secretion while metoclopramide increases
the lower oesophageal sphincter (LOS) tone, speeds
gastric emptying and lowers gastric fluid volume.
Because PONV has a multifactorial etiology, the use
of a combination of agents, acting on different
receptors and the adoption of a multimodal approach
may achieve a significant improvement in the
management . Droperidol, a buterophenone used
in anaesthesia as an antiemetic was associated with
QTc segment prolongation and/or
, which in some cases resulted in fatalcardiac
arrhythmias . However, the UK Medicine Control
Agency (MCA) has allowed the continued acute use
of droperidol in anesthesia and as an antiemetic. A
recent study compared premedication with
transdermal scopolamine (TDS) with droperidol and
ondansetron for antiemetic prophylaxis as part of a
multimodal regimen. This showed that scopolamine
1.5mg was as effective as droperidol 1.25mg IV or
ondansetron 4mg IV in preventing nausea and
vomiting in the early and late postoperative periods.
However, the use of a TDS patch is more likely to
produce a dry mouth .
The creation of a pneumoperitoneum allows the
surgeons to visualize the abdominal viscera. Carbon
dioxide has high blood solubility and this allows easy
excretion of absorbed gas via the lungs, as well as
minimizing the effects of gaseous embolization. It is
also non-combustible allowing for the use of cautery.
To avoid the build up of nitrous oxide in the
pneumoperitoneum, external venting of the
dangerous peritoneal gas mixture and compensation
by fresh carbon dioxide can be performed in a
calibrated and constant manner . The use of nitrous
oxide , a i r and oxygen fo r crea t ing a
pneumoperitoneum has been abandoned because of
their ability to support combustion. Inert gases such
as helium and argon were experimented upon












abdominal irritation. Unfortunately, these gases are
extremely insoluble and can create potential problems
with the occurrence of gaseous emboli .The
abdominal wall retractor is an innovation, which lifts
the abdominal wall allowing visualization of the
viscera without use of a pneumoperitoneum . The use
of this retractor avoids the problems of decreased
pulmonary compliance and lung volumes, avoids the
carbon dioxide load, and minimizes changes in venous
return and systemic venous resistance. A study by
Pelosi on 72 consecutive patients using the abdominal
retractor reported ease of use and excellent surgical
exposure without wound related complications .
Despite the minimal invasiveness of laparoscopic
procedures, patients do experience some postoperative
pain. Innervation of the fallopian tubes is almost
entirely under the control of autonomic nerves.
Parasympathetic cholinergic stimulation acts via
intramural muscarinic receptors to increase smooth
muscle tone. In general, smooth muscle spasm is
clinically associated with diffuse, colicky pain. The
contribution of the cholinergic system is supported by
evidence that the anticholinergic agent glycopyrrolate
decreased the incidence of pain following this
procedure and that the pain is spasmodic in nature .
Buscopan (hyoscine N-butylbromide) , an
anticholinergic agent used commonly in the treatment
of smooth muscle spasm of biliary and urogenital
origin, has been shown not to have an analgesic effect
following laparoscopic sterilization with Filshie
clips . Amongst the anticholinergics, glycopyrrolate
is the most suitable agent against pain induced by tubal
spasm .The pain of laparoscopic sterilization is
greater than that after laparoscopy alone. This is due to
the clips or rings applied on the fallopian tubes, which
induces ischaemia or spasm. Rings tend to cause more
pain than clips suggesting that the major cause of pain
enhancement is tubal spasm . Other causes of pain are
peritoneal irritation by blood from the trauma and
shoulder tip pain referred from the diaphragm.
Systemic analgesia (tramadol and co-dydramol) may
provide adequate postoperatively pain relief. Non-
steroidal anti-inflammatory drugs (e.g. ketorolac and
diclofenac sodium) and paracetamol/codeine
combinations have also been used for postoperative
analgesia with varying degrees of success . Other
methods which have been tried to reduce the amount of
postoperative pain produced by Filshie clips include
the following: local anaesthetics applied to these clips,
injected into the mesosalpinx, administered via the
cervix or sprinkled around the peritoneum . The
infiltration of the entry port with 0.5% bupivacaine
with adrenaline and the intraperitoneal administration
of 10-20 mls of 0.5% bupivacaine with or without
adrenaline, following laparoscopic sterilization and
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These local anaesthetic methods require the
assistance and the cooperation of the operating
surgeons. Ketamine, widely used in developing
countries for its analgesic and anaesthetics properties
was found to produce preemptive analgesia in
women undergoing laparoscopic gynaecological
surgery when given at a dose of 0.15 mg/ kg before
skin incision. No demonstrable haemodynamic or
psychotomimetic side effects were found at this
dosage . Multimodal analgesic regimens that use
non-opioid analgesics (e.g. local anaesthetics, non-
steroidal anti-inflammatory drugs, cyclo-oxygenase
inhibitors, acetaminophen, ketamine and alpha 2-
agonists) to supplement opioids analgesics have
been successfully used for postoperative pain
management. The opioids sparing effects of these
compounds have lead to a reduced incidence of
nausea, vomiting, constipation, urinary retention,
respiratory depression and sedation associated with
the use of opioids .
Selective spinal anaesthesia (SSA) is defined as 'the
practice of employing minimal doses of intrathecal
agents so that only the nerve roots supplying a
specific area and only the modalities that require to
be anaesthetized are affected' . Dorsal column and
motor functions are essentially preserved with SSA,
such that patients are able to ambulate at the end of
surgery . Various studies on selective spinal
anaesthesia for daycase laparoscopy using mini dose
hypobaric lidocaine-fentanyl or sufentanil
techniques were found to have a higher patient
acceptance, no hypotension and faster recovery
when compared with the conventional dose
hyperbaric lidocaine and general anaesthesia .
Daycase patients should meet all the criteria for
discharge and home readiness before discharge.
Among the criteria are orientation in time, place and
person and stable vital signs for over 60 minutes.
Other criteria are ability to ambulate unassisted,
ability to tolerate oral fluids, ability to void and
absence of significant pain and bleeding. Nurse-led
discharge according to set criteria can be used. Home
readiness does not imply that the patient has the
ability to take important decisions, to drive or to
return to work. These street fitness activities require
complete pyschomotor recovery, which is often not
achieved until 24-74 hours postoperatively. Phoning
in by the patient and follow up phone calls must be
encouraged because of the possibility of severe pain
or post discharge nausea and vomiting (PDNV). The
take home drugs should be prescribed by the
anaesthetist and this should include an antiemetic
and an analgesic to ensure patient comfort at home
and to prevent unanticipated admission.
Daycase laparoscopic procedures are increasingly









patients. Newer drugs with rapid onset and offset,
minimal and insignificant risks and short duration of
action are now available. The problems associated
with carbon dioxide pneumoperitoneum can be
prevented by a balanced general anaesthetic technique
with efficient ventilation of the lungs. While
convenience, habit of the anaesthetist and drug
availability may still determine the choice of agents,
the morbidity in the form of pain, nausea and vomiting,
dizziness and delayed mobilization can be prevented.
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attachment at the Department of Anaesthetics,
Hillingdon Hospital, Uxbridge, UK and Prof N.D.
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University of Port Harcourt for carefully reading this
article.
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